Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Castro, S. Wenzel, R. Kolbeck, D. Khatry, W. Christine, Y. Wu, R. van der Merwe, E. Bleecker (St. Louis, Pittsburgh, Gaithersburg, Winston-Salem, United States Of America). LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma. Eur Respir J 2014; 44: Suppl. 58, 2909

Member's Comments

No comment yet.

Related content which might interest you: Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 Serious asthma exacerbations in a hospital setting Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Immunology indices in severe bronchial asthma with different levels of disease control in children Source: Annual Congress 2013 –Asthma Year: 2013 Lung function response to omalizumab in severe allergic asthma patients in UK clinical practice: APEX II study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Outcomes of immunotherapy of patients with COPD Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Fungal sensitization in patients with moderate and severe asthma Source: International Congress 2014 – Clinical allergy Year: 2014 LATE-BREAKING ABSTRACT: Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting the allergen-induced early asthmatic response Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Small airway indices, bronchodilator response and asthma control in children Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 LATE-BREAKING ABSTRACT: A phase 2a study of benralizumab in adults with COPD Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Omalizumab reduces exacerbations and healthcare utilisation in severe allergic asthma patients UK clinical practice - APEX II study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of asthma . A comparative study Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Omalizumab in allergic eosinophilic asthma and lung eosinophil numbers: A 78-week randomized controlled trial Source: Annual Congress 2013 –Treatment of asthma Year: 2013 QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Asthma clusters in a real asthmatic population, treated in secondary medical care Source: International Congress 2014 – Asthma: clinical problems Year: 2014 The impact of psychological distress on allergic rhinitis and asthma control Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Tiotropium for uncontrolled asthma (a meta-analysis) Source: Annual Congress 2013 –Treatment of asthma Year: 2013 LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Intervening in allergic asthma Year: 2014